Immunopathogenesis of COVID-19: Summary and Possible Interventions
Since the onset of the COVID-19 pandemic in the fall of 2019 over 4 million people have been infected and over 280,000 have died (1). Information about the SARS-CoV2 virus is evolving rapidly. At this time there are no interventions proven to be effective for cases infected with SARS-CoV2. Current k...
Main Authors: | Francois Henri Jacques, Erik Apedaile |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.564925/full |
Similar Items
-
The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01) -
Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
by: A. Balkhair, et al.
Published: (2021-02-01) -
COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm
by: Cirino Botta, et al.
Published: (2021-01-01) -
COVID‐19: lambda interferon against viral load and hyperinflammation
by: Evangelos Andreakos, et al.
Published: (2020-06-01) -
COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
by: Carlo Contini, et al.
Published: (2020-08-01)